Concepedia

H.A. Zhang

HZ

Statistics

Publications

1

Citations

22

H-Index

1

Active since

2023

Affiliations

KU Leuven(Current)

H.A. Zhang is an author at KU Leuven.

Publications per year

2023–2023

1

Publications

1

LBA1 Final analysis of the placebo-controlled randomised phase III IMpassion031 trial evaluating neoadjuvant atezolizumab (atezo) plus chemotherapy (CT) followed by open-label adjuvant atezo in patients (pts) with early-stage triple-negative breast cancer (eTNBC)

C.H. Barrios, Nadia Harbeck, H.A. Zhang et al. · ESMO Open · 2023 · 22 citations · Full text

1–1 of 1